s25626
NM_001136138.2
NM_001287218.1
NM_001287219.1
NM_001287220.1
NM_001287221.1
NM_012424.4
XM_005273095.1
XM_005273096.1
XM_006711272.1
XM_017001024.1
XM_017001025.1
XM_017001026.1
XM_017001027.1
XM_017001028.1
XM_017001029.1
XM_017001030.1
XM_017001031.1
XM_017001032.1
XM_017001033.1
XM_017001034.1
12%(+/-2% mRNA remaining)(HeLa cell line) [TaqMan® Assay ID: Hs00179396_m1]
HeLa cells were reverse transfected with 5nM gene-specific Silencer® Select siRNA or 5nM Silencer® Select Negative Control #2 siRNA. 48 hours post-transfection, gene expression analysis was performed using the TaqMan® Gene Expression Cells-to-CT Kit and appropriate TaqMan® Gene Expression Assays. 18S rRNA was used as an endogenous control. Validation results are expressed as average percent mRNA remaining, relative to Negative Control siRNA-treated samples, along with the standard deviation of multiple independent experiments.